PhytoHealth Corporation

Taiwan Stock Exchange 4108.TW

PhytoHealth Corporation Price to Sales Ratio (P/S) on January 14, 2025: 18.41

PhytoHealth Corporation Price to Sales Ratio (P/S) is 18.41 on January 14, 2025, a -34.82% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

PhytoHealth Corporation 52-week high Price to Sales Ratio (P/S) is 30.01 on February 26, 2024, which is 63.01% above the current Price to Sales Ratio (P/S).
PhytoHealth Corporation 52-week low Price to Sales Ratio (P/S) is 18.18 on December 23, 2024, which is -1.27% below the current Price to Sales Ratio (P/S).
PhytoHealth Corporation average Price to Sales Ratio (P/S) for the last 52 weeks is 23.62.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

Taiwan Stock Exchange: 4108.TW

PhytoHealth Corporation

CEO	Ms. Yi-Li Lee
IPO Date	July 16, 2008
Location	Taiwan
Headquarters	No.167, Fu Hsing North Road
Employees	84
Sector	Health Care
Industries Pharmaceuticals

Description

PhytoHealth Corporation researches and develops, manufactures, and sells pharmaceutical drugs, cosmetics, Class B medicines, and supplementary foods and other related products. Its products include PG2 Lyophilized injection for the treatment of cancer related fatigue; EnerCharge, which is used in enhancing physical strength, maintaining good spirits, and enhancing health maintenance activities; ReyeasCleanse health food capsules; and EnerCharge, an energy drink. The company also offers precision medical equipment and instrument; medical diagnosis software; and computer-aided diagnosis system authorization services. PhytoHealth Corporation was incorporated in 1998 and is based in Taipei, Taiwan.

Key trends

Past 5 years